12 Health Care Stocks Moving In Tuesday's Intraday Session

Gainers

  • Infinity Pharmaceuticals INFI stock moved upwards by 60.9% to $0.14 during Tuesday's regular session. Trading volume for this security as of 13:30 EST is 108.7 million, which is 11458.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $12.9 million.
  • Vivos Therapeutics VVOS shares moved upwards by 59.0% to $0.41. The current volume of 64.5 million shares is 19105.0% of Vivos Therapeutics's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $12.4 million.
  • Cardiff Oncology CRDF stock rose 35.03% to $2.12. Trading volume for Cardiff Oncology's stock is 8.4 million as of 13:30 EST. This is 5382.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $94.7 million.
  • Fresh2 Group FRES stock rose 28.12% to $3.23. The market value of their outstanding shares is at $20.2 million.
  • Tilray Brands TLRY stock moved upwards by 27.59% to $2.83. Trading volume for this security as of 13:30 EST is 87.4 million, which is 444.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.9 billion.
  • electroCore ECOR shares moved upwards by 22.75% to $6.15. The current volume of 105.1K shares is 377.1% of electroCore's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $29.2 million.

Losers

  • Vistagen Therapeutics VTGN stock fell 37.7% to $8.13 during Tuesday's regular session. As of 13:30 EST, Vistagen Therapeutics's stock is trading at a volume of 7.5 million, which is 712.3% of its average full-day volume over the last 100 days. The company's market cap stands at $64.9 million.
  • Mallinckrodt MNK shares fell 21.83% to $1.42. The current volume of 7.7 million shares is 165.8% of Mallinckrodt's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $18.6 million.
  • Tempest Therapeutics TPST stock declined by 19.42% to $0.69. As of 13:30 EST, Tempest Therapeutics's stock is trading at a volume of 1.2 million, which is 1747.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $7.9 million.
  • Arcturus Therapeutics ARCT shares decreased by 19.25% to $25.72. The current volume of 775.0K shares is 179.2% of Arcturus Therapeutics's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $683.1 million. As per the news, the Q2 earnings report came out yesterday.
  • Axogen AXGN shares declined by 18.79% to $6.72. As of 13:30 EST, this security is trading at a volume of 2.9 million shares, making up 1609.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $288.6 million. As per the press release, Q2 earnings came out yesterday.
  • FibroGen FGEN shares declined by 18.65% to $1.44. The current volume of 5.3 million shares is 191.5% of FibroGen's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $140.5 million. The company's, Q2 earnings came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!